Latest Medical biotechnology industry News

ArQule and Fate Therapeutics soar; Sanofi and Diplomat fall

Dec. 9, 2019 4:35 PM EST

NEW YORK (AP) — Stocks that moved substantially or traded heavily on Monday: Sanofi, down 73 cents to $45.30 The drug developer is buying biotechnology firm Synthorx, which focuses on potential cancer treatments, for $2.5 billion. ArQule Inc., up $10.04 to $19.70 The biotechnology company is being bought...

Novartis to buy The Medicines Company for $9.7 billion

Nov. 24, 2019 5:07 PM EST

Swiss pharmaceutical company Novartis has reached a deal to buy cholesterol drugmaker The Medicines Co. for $9.7 billion. Novartis will pay $85 per share for the New Jersey biotech company, a sharp increase over The Medicine Co.’s Friday closing price of $68.55 per share. The deal is worth $9.7 billion,...

Court OKs conviction of pharma executive Shkreli's ex-lawyer

Oct. 30, 2019 1:23 PM EDT

NEW YORK (AP) — An appeals court in New York says the former lawyer of a notorious pharmaceutical executive was properly convicted in a financial fraud case. The 2nd U.S. Circuit Court of Appeals on Wednesday rejected Evan Greebel's challenge to his December 2017 conviction at a Brooklyn trial. Prosecutors...

Asian stocks follow Wall Street lower after mixed earnings

Oct. 23, 2019 12:23 AM EDT

BEIJING (AP) — Asian stock markets followed Wall Street lower Wednesday after major companies reported mixed earnings and an EU leader said he would recommend the trade bloc allow Britain to delay its departure. Benchmarks in Shanghai, Tokyo and Hong Kong all declined. U.S. shares retreated, led by a tech...